Cardiac Rhythm Devices Market Worth $13 Billion

The global market for cardiac rhythm management (CRM) devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to Kalorama Information.

The market research publisher said the sector has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets. There also is an increasing trend to upgrade to more portable devices and devices, which have added benefits such as magnetic resonance imaging compatibility. The finding was made in a Kalorama Information report titled, “Cardiac Rhythm Management Device Markets.”

“An aging population more likely to be diagnosed with advanced cardiovascular disease is a driver as is the increasing use of devices for prevention and early intervention,” said Bruce Carlson, publisher of Kalorama Information. “Replacement of existing units, upgrades, emerging markets are also factors.”

As cardiovascular disease is the most common cause of mortality in the developed world, it is natural that a great deal of emphasis should be placed on its treatment and cure. Moreover, as one cardiovascular condition very often influences the onset of others (e.g., hypertension resulting in stroke or congestive heart failure or atherosclerosis resulting in angina or myocardial infarction) there is an urgency to discovering the root causes of cardiovascular disease in the hopes of not only treating the initial conditions, but also preventing them.

• Defibrillators, which are electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation, cardiac dysrhythmias, and pulseless ventricular tachycardia. These devices can be implanted inside the body, externally, or transvenously. The goal of the technology is to re-establish normal rhythm of the heartbeat; and

• Pacemakers  ,   small electrical generators that control a patient’s heartbeat. They generally are used when a patient has a chronic heart rhythm problem.

The report claims the demand to integrate data processing capabilities and electronic medical record transfer options also has fueled the market.  

Kalorama’s report breaks out the market for every segment and sub-segment within each of these broad categories. It also has CRM markets for countries, including Germany, France, UK, Australia, Spain, Italy, Canada, and Brazil.